Stay updated on VenDex vs PomDex in t(11;14)+ MM Clinical Trial

Sign up to get notified when there's something new on the VenDex vs PomDex in t(11;14)+ MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VenDex vs PomDex in t(11;14)+ MM Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.5.0 was added to the page, replacing the previous Revision: v3.4.3 label.
    Difference
    0.0%
    Check dated 2026-03-23T13:43:23.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Added related topics 'Multiple myeloma' and 'MedlinePlus Genetics' and updated the page revision from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-09T01:56:36.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    CANOVA primary results publication added: Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-positive relapsed or refractory MM published in J Clin Oncol (2026; 44(3):164-175; DOI: 10.1200/JCO-25-00924; Epub 2025-12-10). The earlier ahead-of-print citation was replaced with the updated JCO citation.
    Difference
    0.0%
    Check dated 2026-02-15T12:34:47.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    A small update to the site's revision history was made, adding Revision: v3.4.1 and removing Revision: v3.4.0, reflecting internal version control rather than changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-08T04:53:55.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Removed 'Multiple Myeloma' and 'MedlinePlus Genetics' from the study page's related topics/keywords. This change removes metadata without altering core trial content or patient information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-01T01:32:59.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The additions introduce a glossary display and related topics, such as Multiple Myeloma and MedlinePlus Genetics, and include visibility of QC-related metadata (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). These changes are minor UI/metadata updates that do not affect core trial content, eligibility, or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-24T22:22:09.000Z thumbnail image

Stay in the know with updates to VenDex vs PomDex in t(11;14)+ MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VenDex vs PomDex in t(11;14)+ MM Clinical Trial page.